Skip to main content
S.M.A.I.O logo

S.M.A.I.O — Investor Relations & Filings

Ticker · ALSMA ISIN · FR0014005I80 LEI · 969500T1Z0DAZXPZMC93 PA Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2025-01-27 Regulatory Filings
Country FR France
Listing PA ALSMA

About S.M.A.I.O

https://smaio.com/

S.M.A.I.O. (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer that develops solutions for spine surgery. The company provides a comprehensive platform, I-Kontrol, which incorporates planning software, adaptive implants, and related services for spine surgeons. This integrated solution is designed to enhance control over surgical procedures to improve safety, performance, and repeatability. The I-Kontrol platform covers the entire surgical workflow, including pre-operative planning (i-PLAN), surgical execution with implants (i-PERFORM), post-operative outcome analysis (i-CHECK), and training programs (i-LEARN). S.M.A.I.O. utilizes clinical data, imaging, and artificial intelligence to advance the treatment of vertebral conditions.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from SMAIO announcing the termination of a development and licensing agreement with NuVasive. It details the strategic implications of this termination, the company's independent growth strategy in the US market, and provides forward-looking statements regarding its business operations. It does not constitute a formal financial report, audit, or proxy statement, but rather a corporate announcement regarding business strategy and partnership status. As it does not fit into specific categories like M&A (it is a termination of a partnership, not a merger or acquisition) or Earnings Release (it is a strategic update, not a quarterly financial result), it falls under the general regulatory announcement category.
2025-01-27 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release issued by SMAIO regarding the termination of a development and license agreement with NuVasive. It provides strategic updates on the company's U.S. market focus and business operations. Since it is a general corporate announcement regarding business strategy and partnership status that does not fit into specific financial reporting or regulatory categories like 10-K or ER, it falls under the general regulatory/corporate announcement category.
2025-01-27 English
Inside Information / Information on annual revenues
Earnings Release Classification · 1% confidence The document is explicitly titled '# P R E S S R E L E A S E' and begins by announcing 'SMAIO announces 2024 sales of €5.5m'. It provides key financial highlights for the full year ending December 31, 2024, including sales figures, growth percentages, and commentary from the CEO. This format—a brief announcement of period results with key figures—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), nor is it a transcript (CT) or a formal regulatory filing like a DEF 14A or 10-Q/K. The document also mentions the date for the 'Full-year 2024 results: April 15, 2025', confirming this is the preliminary sales announcement preceding the full results filing. Therefore, the classification is Earnings Release (ER). FY 2024
2025-01-21 English
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces the company's financial results for the year ended December 31, 2024. It provides key figures, including total revenue and revenue breakdown by geography, and discusses business highlights and future outlook. The text explicitly states the figures are "Chiffres non audités" (Unaudited figures) and announces the date for the official "Résultats annuels 2024" (Annual 2024 results) release on April 15, 2025. Since this document is the initial announcement of periodical financial results, providing key highlights and figures before the formal filing, it fits the definition of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the formal Audit Report (AR). FY 2024
2025-01-21 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Transaction in Own Shares Classification · 1% confidence The document is titled "Bilan semestriel du Contrat de Liquidité contracté avec TP ICAP" (Semi-annual statement of the Liquidity Contract concluded with TP ICAP) and reports on the status of the liquidity contract as of 31/12/2024, detailing shares and cash held, and transactions executed during the second half of 2024. This type of regular disclosure regarding market making or liquidity provision arrangements is a specific corporate action announcement, often related to share trading activity. It is not a full Annual Report (10-K), an Interim Report (IR), or a standard Earnings Release (ER). It details transactions in the company's own shares (buy/sell activity managed by the liquidity provider), which aligns closely with the definition of 'Transaction in Own Shares' (POS). While it is a periodic report on share activity, it is specifically about the liquidity contract, which is a form of share management/transaction reporting. Given the options, 'Transaction in Own Shares' (POS) is the most fitting category for a report detailing the activity of a share liquidity contract, as it directly concerns the company's shares being traded on the market under this arrangement. It is a formal report, not just an announcement of a report (RPA/RNS).
2025-01-07 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL" (Monthly information relating to the total number of shares and voting rights comprising the share capital). It explicitly references French commercial code (Article L.233-8-II du Code de Commerce) and AMF regulations (Article 223-16 du règlement général de l'AMF). It provides a monthly breakdown (Période: Décembre 2024) of the total number of shares and voting rights. This content directly relates to changes in the capital structure and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) definition, as it reports the current state of the capital base. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), as it reports the total capital, not an individual transaction or threshold crossing by a specific entity.
2025-01-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.